home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

When Three Is Better Than Two

 
  January, 9 2008 22:32
your information resource in human molecular genetics
 
     

People with Down's syndrome seem to be less susceptible to cancers - an observation that may at least partly derive from their having an extra copy of the chromosome responsible for the syndrome, chromosome 21. A paper in Nature puts this idea to the test in mouse models of Down's syndrome and finds that the animals are indeed less likely to develop colon cancer.

Roger Reeves and colleagues pinpoint a gene, known as Ets2, on chromosome 21 that seems to confer protection in these mice. The authors explain their finding as a 'dosage' effect: having three copies of chromosome 21 instead of the normal two means that more Ets2 protein is produced. This came as a surprise, because Ets2 is generally thought to encourage tumours to grow.

The discovery could be exploited in developing a drug to promote cancer resistance, suggest the authors.

CONTACT

Roger Reeves (The Johns Hopkins University, Baltimore, MD, USA)
E-mail: rreeves@jhmi.edu

David Threadgill (University of North Carolina, Chapel Hill, NC, USA) N&V Author
E-mail: dwt@med.unc.edu

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.